Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide MPF sustained-release safety, PK, and biomarker study in healthy volunteers and type 2 diabetes
NL-OMON44056Active, not recruiting
- Sponsor
- Avadel Pharmaceuticals
- Start
- Jul 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, open-label trial of exenatide in type 2 diabetes mellitus (T2DM) (5 arms), sponsored by Avadel Pharmaceuticals. Started Jul 2015; status: active, not recruiting.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON44056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44056.